Combining nicotinamide mononucleotide and nicotinamide riboside creates a comprehensive approach for increasing cellular NAD+. While NR gets transported through specialized transporters and requires riboside kinase conversion, nicotinamide mononucleotide employs the Slc12a8 transporter for rapid conversion. This dual-pathway approach maximizes NAD+ restoration by targeting different cellular processes.